{
    "2020-12-18": [
        [
            {
                "time": "2021-01-15",
                "original_text": "J&J (JNJ) Coronavirus Vaccine Candidate Study Fully Enrolled",
                "features": {
                    "keywords": [
                        "J&J",
                        "Coronavirus",
                        "Vaccine",
                        "Candidate",
                        "Study",
                        "Fully",
                        "Enrolled"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2021-01-15",
                "original_text": "The 7 Best Startups You Can Buy on StartEngine Right Now",
                "features": {
                    "keywords": [
                        "Startups",
                        "StartEngine"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "startups",
                        "investing"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-01-15",
                "original_text": "Pharma Stock Roundup: FDA Emergency Nod to PFE/BNTX COVID-19 Vaccine, AZN to Buy ALXN",
                "features": {
                    "keywords": [
                        "Pharma",
                        "Stock",
                        "FDA",
                        "Emergency",
                        "Nod",
                        "PFE/BNTX",
                        "COVID-19",
                        "Vaccine",
                        "AZN",
                        "ALXN"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-01-15",
                "original_text": "Who Will Be The Kingpin Of Covid Vaccines? It Might Not Be Pfizer",
                "features": {
                    "keywords": [
                        "Kingpin",
                        "Covid",
                        "Vaccines",
                        "Pfizer"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2021-01-15",
                "original_text": "Johnson & Johnson's Late-Stage Trial Of Single Dose COVID-19 Vaccine Fully Enrolled",
                "features": {
                    "keywords": [
                        "Johnson",
                        "&",
                        "Johnson's",
                        "Late-Stage",
                        "Trial",
                        "Single",
                        "Dose",
                        "COVID-19",
                        "Vaccine",
                        "Fully",
                        "Enrolled"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2021-01-15",
                "original_text": "J&J says late-stage COVID-19 vaccine trial fully enrolled",
                "features": {
                    "keywords": [
                        "J&J",
                        "late-stage",
                        "COVID-19",
                        "vaccine",
                        "trial",
                        "fully",
                        "enrolled"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            }
        ]
    ]
}